Haesun Choi

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer
    Vikas Kundra
    Department of Radiology, The University of Texas M D Anderson Cancer Center, Box 57, 1515 Holcombe Blvd, Houston, TX 77030, USA
    AJR Am J Roentgenol 189:830-44. 2007
  2. ncbi Case 69: extramedullary hematopoiesis
    Haesun Choi
    Divisions of Diagnostic Imaging and Pathology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, PO Box 57, Houston, TX 77030, USA
    Radiology 231:52-6. 2004
  3. ncbi Response evaluation of gastrointestinal stromal tumors
    Haesun Choi
    University of Texas, MD Anderson Cancer Center, Houston Texas 77030, USA
    Oncologist 13:4-7. 2008
  4. ncbi Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria
    Haesun Choi
    Division of Diagnostic Imaging and Department of Sarcoma Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:1753-9. 2007
  5. ncbi Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate
    Lucian R Chirieac
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:2237-44. 2006
  6. ncbi We should desist using RECIST, at least in GIST
    Robert S Benjamin
    Department of Sarcoma Medical Oncology and the Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:1760-4. 2007
  7. ncbi A fast spin echo two-point Dixon technique and its combination with sensitivity encoding for efficient T2-weighted imaging
    Jingfei Ma
    Department of Imaging Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Magn Reson Imaging 23:977-82. 2005
  8. ncbi A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis
    John C McAuliffe
    The University of Texas Houston, Houston, TX, USA
    Ann Surg Oncol 16:910-9. 2009
  9. ncbi CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings
    Haesun Choi
    Department of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    AJR Am J Roentgenol 183:1619-28. 2004
  10. ncbi Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor
    Eric P Kleinbaum
    Department of Sarcoma Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Cancer 122:711-8. 2008

Detail Information

Publications35

  1. ncbi Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer
    Vikas Kundra
    Department of Radiology, The University of Texas M D Anderson Cancer Center, Box 57, 1515 Holcombe Blvd, Houston, TX 77030, USA
    AJR Am J Roentgenol 189:830-44. 2007
    ....
  2. ncbi Case 69: extramedullary hematopoiesis
    Haesun Choi
    Divisions of Diagnostic Imaging and Pathology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, PO Box 57, Houston, TX 77030, USA
    Radiology 231:52-6. 2004
  3. ncbi Response evaluation of gastrointestinal stromal tumors
    Haesun Choi
    University of Texas, MD Anderson Cancer Center, Houston Texas 77030, USA
    Oncologist 13:4-7. 2008
    ..Identifying appropriate treatment response criteria is essential to optimize treatment for patients with GIST...
  4. ncbi Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria
    Haesun Choi
    Division of Diagnostic Imaging and Department of Sarcoma Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:1753-9. 2007
    ....
  5. ncbi Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate
    Lucian R Chirieac
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:2237-44. 2006
    ..CONCLUSIONS: Patients with the appropriate clinical presentation and KIT-positive GIST tumors appear to benefit from IM independent of the level of KIT or the expression of CD34, SMA, desmin, or S-100 protein by IHC...
  6. ncbi We should desist using RECIST, at least in GIST
    Robert S Benjamin
    Department of Sarcoma Medical Oncology and the Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:1760-4. 2007
    ..This study was designed to validate these observations in an independent data set...
  7. ncbi A fast spin echo two-point Dixon technique and its combination with sensitivity encoding for efficient T2-weighted imaging
    Jingfei Ma
    Department of Imaging Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Magn Reson Imaging 23:977-82. 2005
    ....
  8. ncbi A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis
    John C McAuliffe
    The University of Texas Houston, Houston, TX, USA
    Ann Surg Oncol 16:910-9. 2009
    ..02). Imatinib appears to be safe and may be considered for patients undergoing surgical resection of their GIST. Radiographic response and tumor cell apoptosis occur within the first week of imatinib therapy...
  9. ncbi CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings
    Haesun Choi
    Department of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    AJR Am J Roentgenol 183:1619-28. 2004
    ..RECIST, using only tumor size, was unreliable for monitoring GISTs during the early stage of imatinib mesylate treatment...
  10. ncbi Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor
    Eric P Kleinbaum
    Department of Sarcoma Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Cancer 122:711-8. 2008
    ..Germ-line deletion of KIT codon 579 in GIST is associated with clinical benefit from imatinib, limited utility of mitoses to predict malignant potential, and a novel homozygous deletion of this codon in one individual...
  11. ncbi Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib
    Xie Hong
    Department of Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Radiographics 26:481-95. 2006
    ..Development of a nodule within the treated tumor is unique to GISTs and indicates recurrence regardless of changes in tumor size...
  12. ncbi Imatinib resistance in gastrointestinal stromal tumors
    Lei L Chen
    Department of Sarcoma, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Curr Oncol Rep 7:293-9. 2005
    ..The established mechanisms and potential mechanisms of imatinib resistance in GISTs, the imaging studies indicative of early development of imatinib resistance, and the management of imatinib-resistant GISTs are discussed...
  13. ncbi Imaging of gastrointestinal stromal tumors and assessment of benefit from systemic therapy
    Piyaporn Boonsirikamchai
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Hematol Oncol Clin North Am 23:35-48, vii. 2009
    ..The roles of MRI and ultrasound are also described...
  14. ncbi Fast spin-echo triple-echo dixon (fTED) technique for efficient T2-weighted water and fat imaging
    Jingfei Ma
    Department of Imaging Physics, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Magn Reson Med 58:103-9. 2007
    ....
  15. ncbi Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
    Min S Park
    Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Cancer 117:4939-47. 2011
    ..An optimal systemic treatment strategy for advanced HPC/SFT has not yet been identified...
  16. ncbi Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate
    Dejka M Steinert
    Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, 77030, USA
    Cancer 106:1617-23. 2006
    ..Larger studies may help elucidate the influence of Bcl-2 expression on PFS after therapy with imatinib...
  17. ncbi MR imaging for preoperative evaluation of primary rectal cancer: practical considerations
    Harmeet Kaur
    Department of Diagnostic Radiology, University of Texas M D Anderson Cancer Center, 1400 Pressler St, Unit 1473, Houston, TX 77030, USA
    Radiographics 32:389-409. 2012
    ..Three-dimensional T2-weighted imaging provides multiplanar capability with a superior signal-to-noise ratio compared with two-dimensional T2-weighted imaging...
  18. ncbi Planning and follow-up after ablation of hepatic tumors: imaging evaluation
    Piyaporn Boonsirikamchai
    Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Unit 1473, PO Box 301402, Houston, TX 77230 1402, USA
    Surg Oncol Clin N Am 20:301-15, viii. 2011
    ..Complications of ablative therapy can be identified on post-treatment imaging studies...
  19. ncbi Use of maximum slope images generated from dynamic contrast-enhanced MRI to detect locally recurrent prostate carcinoma after prostatectomy: a practical approach
    Piyaporn Boonsirikamchai
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, 1400 Pressler St, Unit 1473, Houston, TX 77030
    AJR Am J Roentgenol 198:W228-36. 2012
    ....
  20. ncbi Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model
    Haesun Choi
    Department of Radiology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Curr Oncol Rep 7:307-11. 2005
    ..These criteria may have broad applicability as additional targeted therapies become available to treat solid tumors...
  21. ncbi Use of perfluorocarbon compound in the endorectal coil to improve MR spectroscopy of the prostate
    Haesun Choi
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box Unit 368, Houston, TX 77030, USA
    AJR Am J Roentgenol 190:1055-9. 2008
    ..The purpose of this study was to evaluate the utility of perfluorocarbon (PFC) compound compared with air in the endorectal coil in improving the quality of conventional MR spectroscopy of the prostate...
  22. ncbi Fat-suppressed three-dimensional dual echo Dixon technique for contrast agent enhanced MRI
    Jingfei Ma
    Department of Imaging Physics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Magn Reson Imaging 23:36-41. 2006
    ..To develop a fast T1-weighted, fat-suppressed three-dimensional dual echo Dixon technique and to demonstrate its use in contrast agent enhanced MRI...
  23. ncbi Utility of the FIESTA pulse sequence in body oncologic imaging: review
    Priya Bhosale
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 368, Houston, TX 77030, USA
    AJR Am J Roentgenol 192:S83-93 (Quiz S94-7). 2009
    ..In addition, the motion-insensitive FIESTA sequence is useful in surgical planning, particularly in patients with retroperitoneal tumors and pancreatic cancer because it offers excellent visualization of the vascular anatomy...
  24. ncbi Silicone-specific imaging using an inversion-recovery-prepared fast three-point Dixon technique
    Jingfei Ma
    Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    J Magn Reson Imaging 19:298-302. 2004
    ..To demonstrate a new hybrid magnetic resonance imaging (MRI) technique capable of simultaneously generating water-specific and silicone-specific images in a single acquisition...
  25. ncbi A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
    Lei L Chen
    Department of Sarcoma, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. llchen@ mdanderson.org
    Cancer Res 64:5913-9. 2004
    ..Allelic-specific sequencing data show that this new mutation occurs in the allele that harbors original activation mutation of KIT...
  26. ncbi Gel-gel double-lumen silicone breast implant: mimic of intracapsular implant rupture
    Jin-Wei Kwek
    Tan Tock Seng Hospital, Singapore 308433
    AJR Am J Roentgenol 187:W436-7. 2006
  27. ncbi Diagnosis and staging of pancreatic tumors
    Silvana C Faria
    Department of Radiology, Division of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Semin Roentgenol 39:397-411. 2004
  28. ncbi Using a priori structural information from magnetic resonance imaging to investigate the feasibility of prostate diffuse optical tomography and spectroscopy: a simulation study
    Chengyu Li
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center Houston, Texas 77030, USA
    Med Phys 34:266-74. 2007
    ..Prostate DOT is worth further investigation for clinical application...
  29. ncbi NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines
    George D Demetri
    J Natl Compr Canc Netw 5:S1-29; quiz S30. 2007
    ....
  30. ncbi MR imaging of common and uncommon large pelvic masses
    Janio Szklaruk
    Department of Diagnostic Radiology, Division of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Radiographics 23:403-24. 2003
    ....
  31. ncbi Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients
    Steven A Curley
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4095, USA
    Ann Surg 239:450-8. 2004
    ..We performed this prospective analysis to determine early (within 30 days) and late (more than 30 days after) complication rates associated with hepatic tumor RFA...
  32. ncbi Neoplasms of the liver and the bile ducts
    Haesun Choi
    Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Semin Roentgenol 39:412-27. 2004
  33. ncbi Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression
    Lei L Chen
    Department of Internal Medicine, Division of Hematology Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
    Mod Pathol 21:826-36. 2008
    ....
  34. ncbi Detection of small pancreatic tumors with multiphasic helical CT
    Yulia Lisenko Bronstein
    Department of Radiology, Lady Davis Medical Center, Michal St. 7, Haifa 34362, Israel
    AJR Am J Roentgenol 182:619-23. 2004
    ..Improvement in the detection rate of this technique compared with previous techniques lies in the optimization of parenchymal enhancement during the pancreatic phase and the decrease in slice thickness...
  35. ncbi Comparison of treatment volumes and techniques in prostate cancer radiation therapy
    Catherine T Lee
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Am J Clin Oncol 28:618-25. 2005
    ..Because dose-volume parameters have been shown to relate to toxicity, IMRT would appear to be the favored technique for prostate cancer radiation, particularly with regard to nodal treatment...